03:48 PM EST - Akela Pharma, Inc. : reported a consolidated net loss for the first quarter of $400,000 or $0.01 U.S. per share, narrower than net loss of $2.6 million U.S. or $0.12 U.S. per share for the year-ago quarter. Total consolidated revenues for the first quarter dropped to $2 million U.S. from $3.8 million U.S. in the prior-year quarter. Akela Pharma, Inc.
shares T.AKL are trading up $0.03 at $0.13.
